Rajakishore Mishra

Ratu Lohardaga Road
Ranchi, JH 835205, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Targeting systemic lupus erythematosus (SLE) using Withania somnifera derived compounds: A network and molecular dynamics study.

Targeting systemic lupus erythematosus (SLE) using Withania somnifera derived compounds: A network and molecular dynamics study.

Journal: Lupus
Published: November 07, 2025

Correction: Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression.

Correction: Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression.

Journal: Molecular cancer
Published: July 25, 2024

The Neem Limonoid Nimbolide Modulates Key Components of the DNA Damage Response Signalling in Cellular and Animal Models of Oral Squamous Cell Carcinoma.

The Neem Limonoid Nimbolide Modulates Key Components of the DNA Damage Response Signalling in Cellular and Animal Models of Oral Squamous Cell Carcinoma.

Journal: Current pharmaceutical biotechnology
Published: November 14, 2023

Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies.

Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies.

Journal: Pathology, research and practice
Published: October 09, 2023

Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance.

Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance.

Journal: International immunopharmacology
Published: July 01, 2023

Role and regulation of GLUT1/3 during oral cancer progression and therapy resistance.

Role and regulation of GLUT1/3 during oral cancer progression and therapy resistance.

Journal: Archives of oral biology
Published: February 15, 2023

Polymorphisms and haplotypes of TLR-4/9 associated with bacterial infection, gingival inflammation/recession and oral cancer.

Polymorphisms and haplotypes of TLR-4/9 associated with bacterial infection, gingival inflammation/recession and oral cancer.

Journal: Pathology, research and practice
Published: November 14, 2022

ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).

ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).

Journal: Experimental cell research
Published: July 16, 2021

Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal.

Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal.

Journal: Journal of medicinal chemistry
Published: March 19, 2021

Glycogen synthase kinase-3β inactivation promotes cervical cancer progression, invasion, and drug resistance.

Glycogen synthase kinase-3β inactivation promotes cervical cancer progression, invasion, and drug resistance.

Journal: Biotechnology and applied biochemistry
Published: February 27, 2021

Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.

Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.

Journal: Life sciences
Published: January 07, 2021

Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.

Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.

Journal: International immunopharmacology
Published: June 11, 2020
Showing 1-12 of 34

Last Updated: 09/26/2026